CAMBRIDGE, Mass., March 20, 2015 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., today announced that Jonathan Solomon, CEO, will participate on an expert panel, "Neuroscience Therapeutics Development: Challenges, Opportunities and the Road Ahead," at the Massachusetts...
NEW YORK, March 19, 2015 /PRNewswire-USNewswire/ -- By 2030, chronic subdural hemorrhage (SDH) will be the most common adult brain condition requiring neurosurgical intervention in the U.S., according to a new study conducted by researchers at NYU Langone Medical Center. And hospitals and...
WASHINGTON, March 18, 2015 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (PA-02), a Senior Member on the House Appropriations Committee and lead Democrat on the Subcommittee on Commerce, Justice, and Science (CJS) released the following statement recognizing Brain Awareness Week,...
Depression affects about 350 million people worldwide and is the leading cause of disability. Mindfulness training is a promising approach to decreasing depressive symptoms.